Lakefront Biotherapeutics | GLPG - Ativo Circulante





Ativo Circulante Alterar Data
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Biogen USD 7.58B 278.7M 2026-09
Genmab DKK 2.8B 228M 2026-06
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
GRIFOLS EUR 5.35B 40M 2026-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Incyte USD 5.52B 505.2M 2026-09
Merck EUR 13.77B 393M 2026-06
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
UCB EUR 6.05B 733M 2025-12
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09